Archives

by in
Entry Author Date Location
Gilead Sciences Building on HIV, Becoming Cancer Drug Force 04/01/13 National
Drug Development: Let’s Play! 03/21/13 Seattle
If You’ve Got a Real Breakthrough, the FDA Wants To Talk 01/14/13 National
Bridesmaid No More: It is Time For Diagnostics To Shine 07/02/12 National
AIDS Drugs Were the Start. Let’s See More FDA Accelerated Approvals 03/12/12 National
Biotech Is Raising More Cash, But Don’t Be Fooled: Startups are Hurting 01/23/12 National
Merck Leads $10M Funding of HIV Diagnostics Firm Daktari 01/03/12 Boston
The Hepatitis C Market: Biotech’s Version of the Daytona 500 12/12/11 National
Theraclone Names Cliff Stocks, Vet of Icos & Calistoga, as New CEO 12/06/11 Seattle
Sangamo Fails Diabetic Neuropathy Study, Falls Back on HIV, Other Programs 10/03/11 San Francisco
Gates Foundation Adds Novartis Vet, Trevor Mundel, as New Global Health Leader 09/13/11 Seattle
Theraclone Snaps Up $10.6M Financing 09/08/11 Seattle
(Mis)Understanding Drug Discovery: It’s Much Harder Than Rocket Science 09/07/11 Seattle
Theraclone Nabs Industry Award, Scopes Out Extra $10M Financing 09/06/11 Seattle
Dramatic Changes in Hepatitis C Treatment Expected to Continue 09/06/11 San Diego
Seattle Genetics’ Market Debut, Pathway Gets Bought, Theraclone’s Latest Trick Against HIV, & More Seattle-Area Life Sciences News 08/25/11 Seattle
Consortium Find New HIV Antibodies, Zogenix Gets Drug to Clinical End Point, TrovaGene Reclaims Technology, & More San Diego Life Sciences News 08/18/11 San Diego
Scientists Spot New Antibodies Against HIV, Opening Up Potential Path to AIDS Vaccine 08/17/11 National
Gilead HIV Drug Gets FDA OK 08/10/11 San Francisco
Merck and UCSF Team Up to Find New Weapons Against Resurgent HIV 07/20/11 New York
Ken Stuart, the Working Class Kid Who Built a Global Health Hotspot at Seattle Biomed 07/20/11 Seattle
SeaGen’s Big Day at the FDA, Hutch Nabs $20M HIV Grant, Allozyne’s Nasdaq Plan, & More Seattle-Area Life Sciences News 07/14/11 Seattle
Gilead Expands Low-Cost HIV Drug Program 07/12/11 San Francisco
Hutch, Sangamo Win $20M HIV Grant 07/11/11 Seattle
Tachi Yamada, Former Gates Foundation Leader, Joins Frazier for New VC Gig 06/27/11 Seattle
Concert Pharmaceuticals Hits $4 Million Milestone in GSK Alliance 06/20/11 Boston
AVI Biopharma CEO Chris Garabedian Seeks to Avoid Quick Flip, Build Enduring Drug Company 06/02/11 Seattle
Sangamo Shows Early Promise Against HIV, Hemophilia at Gene Therapy Revival Meeting 05/23/11 San Francisco
The Resurgence of Gene and Cell Therapy 05/16/11 Seattle
VCs Turn Up The Heat on FDA to Get Faster, More Predictable 04/25/11 National
Page 1 of 5 next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  3. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  4. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  5. Do You Need an Extended Warranty? Do the Math, Says SquareTrade

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.